Clinical Success Story
Mrs X's Path to Recovery
"Empowering lives through precision medicine and compassionate care in the fight against mHCC."
Diagnosis
mHCC
Clinical Stage
IV
Current Status
Treatment Success
Patient Perspective
NA
Multidisciplinary Treatment Strategy
Started immunotherapy with Atezolizumab + Bevacizumab C6 completed April 2025> Complete Radiological Response
denovo mHCC treated with IMbrave150 trial with Pal RT to bony lesions. Notably, ~5.5% of patients achieved complete responses on atezo/bev.
Clinical Outcomes
Sustainability
6 Mo.
Response
rCR
Quality of Life
10/10
Quick Actions
Want to learn more?
Contact Dr. Arifur Rahman's team to explore personalized treatment options and clinical outcomes research.
Contact Us